Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population

Pediatric Neurosurgery

Volumn 47, Issue 4, 2012, Pages 266-271

  Abd El Barr, Muhammad M ^a   Cox, J Bridger ^a   Antonucci, Michael U ^a   Bennett, Jeffrey ^a   Murad, Gregory J A ^a   Pincus, David W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Pediatric spine; Recombinant human bone morphogenetic protein 2; Spinal fusion

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ABSENCE OF SIDE EFFECTS; ACCIDENTAL INJURY; ADOLESCENT; ADULT; BONE SCREW; CASE REPORT; CHILD; DOWN SYNDROME; DRUG SAFETY; FEMALE; FOLLOW UP; FORAMEN MAGNUM; HUMAN; INTERVERTEBRAL DISKECTOMY; KLIPPEL FEIL SYNDROME; KYPHOSIS; LAMINECTOMY; LIQUORRHEA; LOEYS DIETZ SYNDROME; MALE; MEDICAL RECORD REVIEW; MORQUIO SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRIC SURGERY; PIERRE ROBIN SYNDROME; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SPINAL CORD DECOMPRESSION; SPINE FRACTURE; SPINE FUSION; SPINE STABILIZATION; THORACIC SPINE; TRAFFIC ACCIDENT; VERTEBRAL CANAL STENOSIS; WOUND INFECTION;

ADOLESCENT; BONE MORPHOGENETIC PROTEIN 2; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861093827     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000335424     Document Type: Review

References (17)

1. Urist MR, Mikulski A, Lietze A: Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979; 76: 1828-1832.
2. Zdeblick TA, et al: Cervical interbody fusion cages: An animal model with and without bone morphogenetic protein. Spine (Phila Pa 1976) 1998; 23: 758-765; discussion 766.
3. Hecht BP, et al: The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine (Phila Pa 1976) 1999; 24: 629-636.
4. Boden SD, et al: Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976) 1999; 24: 1179-1185.
5. McKay B, Sandhu HS: Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine (Phila Pa 1976) 2002; 27(16 suppl 1):S66-S85.
6. Cahill KS, et al: Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009; 302: 58-66.
7. Burkus JK, et al: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002; 15: 337-349.
8. Burkus JK, et al: Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am 2009; 91: 1181-1189.
9. Poynton AR, Lane JM: Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 2002; 27(16 suppl 1):S40-S48.
10. Haid RW Jr, et al: Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004; 4: 527-538; discussion 538-539.
11. Fahim DK, et al: Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: Safety profile and efficacy in the early postoperative period. Neurosurgery 2010; 67: 1195-1204; discussion 1204.
12. Smucker JD, et al: Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 2006; 31: 2813-2819.
13. Bapat MR, et al: Reconstruction of large iliac crest defects after graft harvest using autogenous rib graft: A prospective controlled study. Spine (Phila Pa 1976) 2008; 33: 2570-2575.
14. Schaaf H, et al: Donor site morbidity after bone harvesting from the anterior iliac crest. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 52-58.
15. Meyer RA Jr, et al: Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine (Phila Pa 1976) 1999; 24: 747-754.
16. Sandhu HS, et al: Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine (Phila Pa 1976) 2002; 27: 567-575.
17. Bet RR, et al: Allograft versus no graft with a posterior multisegmented hook system for the treatment of idiopathic scoliosis. Spine (Phila Pa 1976) 2006; 31: 121-127.